BNIP3 inhibition in triple-negative breast cancer enhanced ROS-mediated mitophagy, promoting metastasis [27], whereas BNIP3 overexpression in hepatocellular carcinoma induced a greater degree of mitophagy, suppressing metastasis [28]. Here, BNIP3 is linked to hepatocellular carcinoma.